What Peptide Therapy Costs in 2026, and How to Read the Prices

By Your Health Magazine Contributor

Your Health Magazine Contributor

. https://YourHealthMagazine.net

More Consumer Health Guides Articles

What Peptide Therapy Costs in 2026, and How to Read the Prices

The same therapy can cost $30 a month or $2,000 a session depending on where you buy it. A guide to what drives peptide therapy pricing and the questions to ask first.

Peptide therapy has moved out of specialty clinics and into everyday health conversations, and the pricing has not kept up with the attention. The same molecule can be sold as a $2,000 clinic drip, a $228 monthly home program, or a $40 bottle of over-the-counter precursor capsules. None of those numbers is automatically wrong. They describe different products, different settings, and different levels of clinical oversight. The problem for consumers is that almost nobody puts them side by side.

Start with a definition. Peptide therapy uses short chains of amino acids, prescribed by a licensed clinician and prepared for that patient by a compounding pharmacy. Compounded medications are not FDA-approved drugs, which is exactly why the clinician’s review matters: a licensed prescriber decides whether the therapy is appropriate for you, and a licensed pharmacy prepares it. When either half is missing, you are not looking at therapy, you are looking at a product.

NAD+ is a useful case study because it is sold in every format at once. One published price comparison recently published a price comparison for it, with each clinic figure tied to a named physician’s published quote. The spread is striking. Clinic IV sessions run from $200 to $500 at the modest end, and $800 to $2,000 per session for high-dose drips. In-clinic injections run $100 to $300 each, which at a weekly schedule works out to $400 to $1,200 a month. Prescribed at-home programs, where a clinician reviews your health history and the medication ships to your door, run $159 to $228 a month depending on the form. Over-the-counter oral precursors run $30 to $60 a month, and they are a different product entirely: no prescription, no clinician, and a different molecule that your body must convert.

Dose-banded therapies add one more wrinkle worth knowing. Compounded semaglutide from telehealth peptide providers commonly runs $198 to $298 a month depending on the prescribed dose, and compounded tirzepatide commonly runs $328 to $548. The range is the honest presentation: the bill rises with the dose a clinician prescribes. A single flat price on a dose-banded therapy should make you ask which dose it describes, because either the low dose is subsidizing the high one or the number you saw is not the number you will pay.

Reading those numbers, the pattern is simple. You are paying for three things in different proportions: the setting, the clinician, and the medication itself. A clinic drip bundles an hour of chair time and staff into every dose. A home program spreads one clinical review across months of medication. Capsules strip the clinical layer out entirely. Which one is right depends on your situation and your clinician’s judgment, but you should always be able to see what you are paying for.

That leads to a set of questions worth asking any provider before spending a dollar on peptide therapy.

First, who reviews my case, and are they licensed in my state? A real program has a licensed clinician making the prescribing decision, and a real answer names the state licensure rather than a generic medical team.

Second, where is the medication compounded? The answer you want is a licensed 503A compounding pharmacy in the United States, preparing your specific prescription. If a company cannot name its pharmacy type, or the product ships from overseas, walk away. There are markets where a hidden supply chain is an inconvenience. Medication you inject is not one of them.

Third, is the full monthly price published before you commit? Medication, clinician oversight, and shipping should be reflected in one visible number, published clearly on the provider’s website before payment is requested.

Fourth, what happens if the clinician says no? Some providers offer an initial clinician review at no cost, while others charge an upfront consultation fee. A free online visit with payment only on prescription means the company has no financial reason to push you through. If declining you costs the platform money, notice who absorbs that cost in each model.

Fifth, is the platform certified? LegitScript certification and Better Business Bureau accreditation are checkable in a minute and filter out most of the operators you should worry about.

Peptide therapy pricing is not mysterious. It is just rarely presented in one place, with sources, in a way a consumer can audit. Ask the five questions, compare the formats honestly, and treat any provider who hides the numbers as having answered them.

Compounded peptides are prescription medications prepared for an individual patient and are not FDA-approved. A licensed clinician decides whether any therapy is appropriate for you.

About the author: B.A. Utterback is the founder of PepScribe, a telehealth practice for peptide and hormone therapy. He is a former Emergency Medical Technician who went on to an executive career in technology, including creating medical mobile applications.